Merck KGaA
Merck KGaA hands over CAR-T therapy business to Intrexon in deal worth $175 million
December 20, 2018Business Services, Medical Communications, Sales and Marketing CAR T, CAR-T, Cancer, Germany, Intrexon, Merck KGaA, darmstadt, oncology
German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …
Merck KGaA and Pfizer’s combo impresses in first-line treatment of advanced kidney cancer
September 12, 2018Research and Development, Sales and Marketing Cancer, Kidney cancer, Merck KGaA, Pfizer, pharma
Bavencio (avelumab), Merck KGaA and Pfizer’s human anti-programmed death ligand-1 (PD-L1) antibody, combined with the latter’s Inlyta (axitinib) has shown …
Merck KGaA announces new Senior Vice President, Head of Global Affairs
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development
Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …
Merck KGaA finds consumer health buyer in P&G for €3.4bn
April 19, 2018Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical
Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …
Working Life: Chris Round, Head of EMEA Region, Merck KGaA
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma
Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …
Top Ten most popular articles on Pharmafile.com this week
January 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten
It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …
Nestle reportedly pulls out in front to buy Merck KGaA consumer health unit with $5 billion bid
January 11, 2018Sales and Marketing Merck KGaA, nestle, pharma
It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …
Merck KGaA posts promising osteoarthritis data
November 6, 2017Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …
GSK eyes healthcare expansion, hits targets due to new drugs
October 26, 2017Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical
During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …
Merck KGaA promotes from within new MEA head
October 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …
Police raid French HQ of Merck KGaA over thyroid drug scandal
October 4, 2017Manufacturing and Production, Research and Development, Sales and Marketing Levothyrox, Merck KGaA, hyperthyroidism, pharma, pharmaceuticals
Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …
Merck KGaA to streamline business with $1bn healthcare sale
September 5, 2017Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
Seven years later, EC gives approval for Merck KGaA’s MS drug
August 25, 2017Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical
In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …
Merck Foundation created and CEO set in place
July 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Foundation, Merck KGaA
Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …
Merck KGaA signs potential $1 billion deal with UK biotech
June 5, 2017Sales and Marketing F-star, Merck KGaA
UK biotech, F-Star, has scored a boost to its coffers with another link-up with a big pharma company, this time …
